Swiss National Bank Madrigal Pharmaceuticals, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Swiss National Bank holds 25,000 shares of MDGL stock, worth $7.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,000

Previous 24,800 0.81%

Holding current value

$7.77 Million

Previous $6.95 Million 23.64%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$212.22 - $292.96 $42,444 - $58,591	200 Added 0.81%	25,000 $5.31 Million
Q2 2024 Aug 08, 2024	BUY	$193.33 - $291.99 $270,662 - $408,786	1,400 Added 5.98%	24,800 $6.95 Million
Q1 2024 May 07, 2024	BUY	$171.37 - $283.23 $342,740 - $566,460	2,000 Added 9.35%	23,400 $6.25 Million
Q4 2023 Feb 06, 2024	SELL	$120.4 - $237.13 $84,280 - $165,991	-700 Reduced 3.17%	21,400 $4.95 Million
Q3 2023 Nov 08, 2023	SELL	$146.04 - $225.78 $817,824 - $1.26 Million	-5,600 Reduced 20.22%	22,100 $3.23 Million
Q2 2023 Aug 09, 2023	BUY	$203.88 - $312.0 $366,984 - $561,600	1,800 Added 6.95%	27,700 $6.4 Million
Q1 2023 May 10, 2023	SELL	$231.06 - $307.08 $693,180 - $921,240	-3,000 Reduced 10.38%	25,900 $6.27 Million
Q4 2022 Feb 08, 2023	BUY	$58.39 - $296.54 $40,873 - $207,578	700 Added 2.48%	28,900 $8.39 Million
Q2 2022 Aug 09, 2022	BUY	$58.04 - $100.2 $226,356 - $390,780	3,900 Added 16.05%	28,200 $2.02 Million
Q1 2022 May 09, 2022	BUY	$55.89 - $101.89 $128,547 - $234,347	2,300 Added 10.45%	24,300 $2.38 Million
Q3 2021 Nov 08, 2021	BUY	$78.35 - $105.02 $62,679 - $84,016	800 Added 3.77%	22,000 $1.76 Million
Q2 2021 Aug 06, 2021	SELL	$97.2 - $137.59 $174,960 - $247,662	-1,800 Reduced 7.83%	21,200 $2.07 Million
Q1 2021 May 07, 2021	BUY	$108.54 - $125.2 $32,562 - $37,560	300 Added 1.32%	23,000 $2.69 Million
Q3 2020 Nov 09, 2020	BUY	$99.78 - $124.21 $29,934 - $37,263	300 Added 1.34%	22,700 $2.7 Million
Q2 2020 Aug 05, 2020	BUY	$60.13 - $125.71 $354,767 - $741,689	5,900 Added 35.76%	22,400 $2.54 Million
Q1 2020 May 08, 2020	BUY	$66.76 - $93.49 $20,028 - $28,047	300 Added 1.85%	16,500 $1.1 Million
Q4 2019 Feb 06, 2020	BUY	$84.28 - $118.5 $25,284 - $35,550	300 Added 1.89%	16,200 $1.48 Million
Q3 2019 Nov 12, 2019	BUY	$84.4 - $106.53 $16,880 - $21,306	200 Added 1.27%	15,900 $1.37 Million
Q2 2019 Aug 02, 2019	BUY	$91.13 - $142.5 $154,921 - $242,250	1,700 Added 12.14%	15,700 $1.65 Million
Q1 2019 May 10, 2019	BUY	$103.48 - $143.84 $41,392 - $57,536	400 Added 2.94%	14,000 $1.75 Million
Q4 2018 Feb 13, 2019	BUY	$94.77 - $215.54 $104,247 - $237,094	1,100 Added 8.8%	13,600 $1.53 Million
Q2 2018 Aug 09, 2018	BUY	$101.55 - $313.9 $40,620 - $125,559	400 Added 3.31%	12,500 $3.5 Million
Q1 2018 May 04, 2018	BUY	$93.35 - $149.04 $18,670 - $29,808	200 Added 1.68%	12,100 $1.41 Million
Q4 2017 Feb 07, 2018	BUY	$39.35 - $97.37 $468,265 - $1.16 Million	11,900	11,900 $1.09 Million

Others Institutions Holding MDGL

# of Institutions

298

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.32B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Madrigal Pharmaceuticals, Inc. Transaction History